Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19

Ira B. Schwartz, James Kaufman, Kun Hu, Simone Bianco
doi: https://doi.org/10.1101/2020.04.16.20068387
Ira B. Schwartz
1U.S. Naval Research Laboratory, Code 6792, Plasma Physics Division, Washington, DC 20375, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Kaufman
2IBM Almaden Research Center, 650 Harry Rd, San Jose, CA 95120-6099
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kun Hu
2IBM Almaden Research Center, 650 Harry Rd, San Jose, CA 95120-6099
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Bianco
2IBM Almaden Research Center, 650 Harry Rd, San Jose, CA 95120-6099
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sbianco@us.ibm.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We introduce a novel mathematical model to analyze the effect of removing non-pharmaceutical interventions on the spread of COVID19 as a function of disease testing rate. We find that relaxing interventions has a strong impact on the size of the epidemic peak as a function of intervention removal time. We show that it is essential for predictive models to explicitly capture transmission from asymptomatic carriers and important to obtain precise information on asymptomatic transmission by testing. The asymptomatic reservoir, reported to account for as much as 85% of transmission, will contribute to resurgence of the epidemic if public health interventions are removed too soon. Use of more basic models that fail to capture asymptomatic transmission can result in large errors in predicted clinical caseload or in fitted epidemiological parameters and, therefore, may be unreliable in estimating the risk of a second wave based on the timing of terminated interventions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

BS acknowledges support from the NRL Base funding no. N0001420WX00410, as well as the Office of Naval Research no. N00001419WX01322

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No relevant data is present in the article

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted April 22, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19
Ira B. Schwartz, James Kaufman, Kun Hu, Simone Bianco
medRxiv 2020.04.16.20068387; doi: https://doi.org/10.1101/2020.04.16.20068387
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19
Ira B. Schwartz, James Kaufman, Kun Hu, Simone Bianco
medRxiv 2020.04.16.20068387; doi: https://doi.org/10.1101/2020.04.16.20068387

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (411)
  • Dentistry and Oral Medicine (68)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4835)
  • Forensic Medicine (3)
  • Gastroenterology (179)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (190)
  • Health Informatics (624)
  • Health Policy (318)
  • Health Systems and Quality Improvement (202)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5306)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (683)
  • Nursing (42)
  • Nutrition (113)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (204)
  • Oncology (439)
  • Ophthalmology (139)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (775)
  • Public and Global Health (1806)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)